In doing so, theyd be following in the footsteps of competitor Novo Nordisk, which received approval for its type 2 diabetes drug semaglutide (Ozempic) as a weight loss drug (Wegovy) in 2021
Patients with a history of rapid weight regain, diabetes, or severe obesity may experience greater rebound during tapering and should consider maintenance therapy
However, these products are typically compounded by third-party facilities without FDA approval or standardized testing
When to Contact Your Doctor About GLP-1 Digestive Side Effects Reach out to your healthcare provider if diarrhea is severe, bloody, accompanied by fever or severe abdominal pain, or lasts longer than 8 weeks
Consistent with the expansion of intestinal surface area observed with the increased food intake that accompanies chronic cold stress, crypt depth was significantly greater with cold stress in WT mice (Fig
This gray-market status creates a regulatory vacuum where responsibility for quality, purity, and safety falls to the individual user rather than health authorities
